These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
218 related articles for article (PubMed ID: 30210453)
1. The Androgen Receptor in Breast Cancer. Giovannelli P; Di Donato M; Galasso G; Di Zazzo E; Bilancio A; Migliaccio A Front Endocrinol (Lausanne); 2018; 9():492. PubMed ID: 30210453 [TBL] [Abstract][Full Text] [Related]
2. An androgen receptor regulated gene score is associated with epithelial to mesenchymal transition features in triple negative breast cancers. Rajarajan S; Snijesh VP; Anupama CE; Nair MG; Mavatkar AD; Naidu CM; Patil S; Nimbalkar VP; Alexander A; Pillai M; Jolly MK; Sabarinathan R; Ramesh RS; Bs S; Prabhu JS Transl Oncol; 2023 Nov; 37():101761. PubMed ID: 37603927 [TBL] [Abstract][Full Text] [Related]
3. Low androgen/progesterone or high oestrogen/androgen receptors ratio in serous ovarian cancer predicts longer survival. Gogola-Mruk J; Pietrus M; Piechowicz M; Milian-Ciesielska K; Głód P; Wolnicka-Glubisz A; Szpor J; Ptak A Reprod Biol; 2024 Jul; 24(3):100917. PubMed ID: 38970978 [TBL] [Abstract][Full Text] [Related]
4. Rangel N; Sánchez IL; Valbuena DS; Rondón-Lagos M Breast Cancer (Dove Med Press); 2024; 16():127-139. PubMed ID: 38505863 [TBL] [Abstract][Full Text] [Related]
5. Androgen receptor as a targeted therapy for breast cancer. Garay JP; Park BH Am J Cancer Res; 2012; 2(4):434-45. PubMed ID: 22860233 [TBL] [Abstract][Full Text] [Related]
6. Prognostic significance of androgen receptor expression in HER2-positive and triple-negative breast cancer. Kucukzeybek BB; Bayoglu IV; Kucukzeybek Y; Yıldız Y; Oflazoglu U; Atahan MK; Taskaynatan H; Alacacioglu A; Yigit S; Tarhan MO Pol J Pathol; 2018; 69(2):157-168. PubMed ID: 30351863 [TBL] [Abstract][Full Text] [Related]
7. Androgen Receptor Expression and Breast Cancer Survival: Results From the Nurses' Health Studies. Kensler KH; Poole EM; Heng YJ; Collins LC; Glass B; Beck AH; Hazra A; Rosner BA; Eliassen AH; Hankinson SE; Winer EP; Brown M; Tamimi RM J Natl Cancer Inst; 2019 Jul; 111(7):700-708. PubMed ID: 30445651 [TBL] [Abstract][Full Text] [Related]
8. The Divergent Function of Androgen Receptor in Breast Cancer; Analysis of Steroid Mediators and Tumor Intracrinology. Bleach R; McIlroy M Front Endocrinol (Lausanne); 2018; 9():594. PubMed ID: 30416486 [TBL] [Abstract][Full Text] [Related]
9. Breast cancer development and progression: Risk factors, cancer stem cells, signaling pathways, genomics, and molecular pathogenesis. Feng Y; Spezia M; Huang S; Yuan C; Zeng Z; Zhang L; Ji X; Liu W; Huang B; Luo W; Liu B; Lei Y; Du S; Vuppalapati A; Luu HH; Haydon RC; He TC; Ren G Genes Dis; 2018 Jun; 5(2):77-106. PubMed ID: 30258937 [TBL] [Abstract][Full Text] [Related]
10. Male breast cancer: a disease distinct from female breast cancer. Gucalp A; Traina TA; Eisner JR; Parker JS; Selitsky SR; Park BH; Elias AD; Baskin-Bey ES; Cardoso F Breast Cancer Res Treat; 2019 Jan; 173(1):37-48. PubMed ID: 30267249 [TBL] [Abstract][Full Text] [Related]
11. Association between androgen receptor status and prognosis in triple negative breast cancer. Sunar V; T Dogan H; Sarici F; Ates O; Akin S; Baspinar B; Aksoy S; Altundag K J BUON; 2018; 23(5):1325-1330. PubMed ID: 30570854 [TBL] [Abstract][Full Text] [Related]
12. Androgen receptor in breast cancer: A wolf in sheep's clothing? A lesson from prostate cancer. Salvi S; Bonafè M; Bravaccini S Semin Cancer Biol; 2020 Feb; 60():132-137. PubMed ID: 31002873 [TBL] [Abstract][Full Text] [Related]
13. Androgen Receptor in Breast Cancer: From Bench to Bedside. Chen M; Yang Y; Xu K; Li L; Huang J; Qiu F Front Endocrinol (Lausanne); 2020; 11():573. PubMed ID: 32982970 [TBL] [Abstract][Full Text] [Related]
14. Bicalutamide plus Aromatase Inhibitor in Patients with Estrogen Receptor-Positive/Androgen Receptor-Positive Advanced Breast Cancer. Lu Q; Xia W; Lee K; Zhang J; Yuan H; Yuan Z; Shi Y; Wang S; Xu F Oncologist; 2020 Jan; 25(1):21-e15. PubMed ID: 31434793 [TBL] [Abstract][Full Text] [Related]
15. Androgen Receptor in Breast Cancer-Clinical and Preclinical Research Insights. Anestis A; Zoi I; Papavassiliou AG; Karamouzis MV Molecules; 2020 Jan; 25(2):. PubMed ID: 31952272 [TBL] [Abstract][Full Text] [Related]
16. Consideration of breast cancer subtype in targeting the androgen receptor. Venema CM; Bense RD; Steenbruggen TG; Nienhuis HH; Qiu SQ; van Kruchten M; Brown M; Tamimi RM; Hospers GAP; Schröder CP; Fehrmann RSN; de Vries EGE Pharmacol Ther; 2019 Aug; 200():135-147. PubMed ID: 31077689 [TBL] [Abstract][Full Text] [Related]
17. Breast cancer stem cells: The role of sex steroid receptors. Giovannelli P; Di Donato M; Galasso G; Di Zazzo E; Medici N; Bilancio A; Migliaccio A; Castoria G World J Stem Cells; 2019 Sep; 11(9):594-603. PubMed ID: 31616537 [TBL] [Abstract][Full Text] [Related]
18. Androgens Induce Invasiveness of Triple Negative Breast Cancer Cells Through AR/Src/PI3-K Complex Assembly. Giovannelli P; Di Donato M; Auricchio F; Castoria G; Migliaccio A Sci Rep; 2019 Mar; 9(1):4490. PubMed ID: 30872694 [TBL] [Abstract][Full Text] [Related]